Langer/Traverso Lab startup Suono Bio has dosed its first patient with SuonoCalm, an ultrasound-based platform that enhances the delivery of nucleic acids, biologics, and other drugs that are too large or delicate to be absorbed effectively by the gastrointestinal tract. Clinical testing begins with a drug for ulcerative colitis (a known cancer risk factor) and could expand to additional diseases, including cancer.